Petar Svorcan

10PUBLICATIONS
16CO-AUTHORS
Medical biochemistry - inorganic elements and compoundsAutoimmunityImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease.

|Aug 27, 2026
Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jun 09, 2026
Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.

|Aug 28, 2025
Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis.

Bojana Milašinović, Sandra Vezmar Kovačević, Srđan Marković

|Aug 28, 2025
Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.

Tamara Knezevic Ivanovski, Marija Milic Perovic, Bojan Stopic

Pageof 2

Frequent Collaborators

7 joint publications

Đorđe Kralj

6 joint publications

Katarina Vučićević

4 joint publications

Srdjan Markovic

3 joint publications

Ana Homšek Ilić